About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: January 5, 2010
DDMAC Warning and NOV Letter Summary, Third and Fourth Quarters, Part 1
It is always important to look back and see what FDA's DDMAC is producing in the way of objections to promotional materials and practices communicated by medical manufacturers. In Part 1 of the examination of the third and fourth quarter … Continue reading
Posted in Warning Letters
4 Comments